(Q38163908)

30 August 2017

title

MicroRNA-21 in breast cancer: diagnostic and prognostic potential (English)

1 reference

30 August 2017

1 reference

J Chen

1

1 reference

30 August 2017

X Wang

series ordinal

2

1 reference

30 August 2017

publication date

19 November 2013

1 reference

Clinical and Translational Oncology

30 August 2017

published in

1 reference

30 August 2017

volume

16

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

225-233

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-013-1132-z

30 August 2017

exact match

0 references

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Analysis of patients with false negative mammography and symptomatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

microRNAs as oncogenes and tumor suppressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

A microRNA expression signature of human solid tumors defines cancer gene targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Expression profiling identifies microRNA signature in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA expression profiles in serous ovarian carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Role of deregulated microRNAs in breast cancer progression using FFPE tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Circulating microRNAs as specific biomarkers for breast cancer detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Biomarkers in cancer staging, prognosis and treatment selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Identification of differentially expressed microRNAs in human male breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA-21 as an indicator of aggressive phenotype in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Plasma processing conditions substantially influence circulating microRNA biomarker levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Dampening enthusiasm for circulating microRNA in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1132-Z

Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor

21 January 2018

1 reference

12 December 2020

Decreased expression of microRNA-31 associates with aggressive tumor progression and poor prognosis in patients with bladder cancer.

1 reference

12 December 2020

Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran

1 reference

12 December 2020

miRNA Biomarkers in Breast Cancer Detection and Management

1 reference

12 December 2020

MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer

1 reference

12 December 2020

Identification of recurrence-related microRNAs in the bone marrow of breast cancer patients.

1 reference

12 December 2020

Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma.

1 reference

12 December 2020

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1

1 reference

12 December 2020

10.1007/S12094-013-1132-Z

Identifiers

DOI

1 reference

release_tfehsl5zsza2lamiucpqyxtajm

30 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tfehsl5zsza2lamiucpqyxtajm

24 November 2022

mapped directly with Wikidata item

1 reference